MAPK8 (JNK, c-Jun N-terminal kinase) in our study has been associated with breast-cancer risk at rs10857561, both in the individual main and hormone-receptor positive (ER + and PR +) stratified analyses, as well as in the SNP-SNP interaction analyses. Here, ESR1 is linked to breast carcinoma.